Savara Reports First Quarter 2021 Financial Results and Provides Business Update

Author's Avatar
May 13, 2021

Savara+Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today reported financial results for the first quarter ending March 31, 2021 and provided a business update.